Politique cantonale vieillissement et santé : rapport du comité d'experts transmis à Monsieur le Conseiller d'Etat Pierre-Yves Maillard le 8 décembre 2011

Notre système de soins vaudois propose de nombreuses prestations de qualité aux personnes âgées. Le canton a été pionnier pour la mise en oeuvre de nombreuses initiatives : aide et soins à domicile, centres de traitements et de réadaptation, unités d'accueil temporaires, bureaux régionaux d'information et d'orientation. Autant de réalisations qui, preuve de leur intérêt, ont largement diffusé au-delà des frontières cantonales. Néanmoins, le vieillissement de la population vaudoise impose d'évaluer ce qui doit être entrepris pour adapter et consolider ces prestations afin de faire face le mieux possible aux formidables enjeux sanitaires liés à ce vieillissement. Ensuite, ces enjeux nécessitent aussi d'imaginer. Imaginer de nouvelles structures, de nouvelles missions, de nouvelles prestations et pratiques. Certaines mesures proposées visent le court terme et sont rapidement réalisables. D'autres nécessitent de modifier notre culture sanitaire, un défi qui demande du temps. Nous souhaitons, dans la politique proposée, initier ce processus dynamique. L'année 2012 marque symboliquement l'entrée en retraite des premiers baby-boomers et annonce la vague démographique qui culminera en 2030 déjà, lorsque un vaudois sur cinq aura plus de 65 ans. La politique "Vieillissement et Santé" proposée ici n'est pas figée. Si ce rapport a pour ambition d'être un outil de référence pour la communauté sanitaire, il ne représente qu'une étape dans les réflexions sur la santé et les soins aux aînés que le canton conduit depuis longtemps, et devra continuer à conduire. La politique qui y est décrite devra être périodiquement évaluée et adaptée. [Auteurs]

Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer.

While genetic mutation is a hallmark of cancer, many cancers also acquire epigenetic alterations during tumorigenesis including aberrant DNA hypermethylation of tumor suppressors, as well as changes in chromatin modifications as caused by genetic mutations of the chromatin-modifying machinery. However, the extent of epigenetic alterations in cancer cells has not been fully characterized. Here, we describe complete methylome maps at single nucleotide resolution of a low-passage breast cancer cell line and primary human mammary epithelial cells. We find widespread DNA hypomethylation in the cancer cell, primarily at partially methylated domains (PMDs) in normal breast cells. Unexpectedly, genes within these regions are largely silenced in cancer cells. The loss of DNA methylation in these regions is accompanied by formation of repressive chromatin, with a significant fraction displaying allelic DNA methylation where one allele is DNA methylated while the other allele is occupied by histone modifications H3K9me3 or H3K27me3. Our results show a mutually exclusive relationship between DNA methylation and H3K9me3 or H3K27me3. These results suggest that global DNA hypomethylation in breast cancer is tightly linked to the formation of repressive chromatin domains and gene silencing, thus identifying a potential epigenetic pathway for gene regulation in cancer cells.

The genome sequence of taurine cattle: a window to ruminant biology and evolution.

To understand the biology and evolution of ruminants, the cattle genome was sequenced to about sevenfold coverage. The cattle genome contains a minimum of 22,000 genes, with a core set of 14,345 orthologs shared among seven mammalian species of which 1217 are absent or undetected in noneutherian (marsupial or monotreme) genomes. Cattle-specific evolutionary breakpoint regions in chromosomes have a higher density of segmental duplications, enrichment of repetitive elements, and species-specific variations in genes associated with lactation and immune responsiveness. Genes involved in metabolism are generally highly conserved, although five metabolic genes are deleted or extensively diverged from their human orthologs. The cattle genome sequence thus provides a resource for understanding mammalian evolution and accelerating livestock genetic improvement for milk and meat production.

2

In 1959, Swerdlow reported a case of a 27-year-old woman with a pelvic tumour that seemed to arise from the peritoneum, in the presence of normal ovaries, fallopian tubes and uterus, and that was histologically similar to papillary serous carcinoma of the ovary [52]. Since then several authors have described this disease using different names, such as extraovarian primary peritoneal carcinoma (EOPPC), peritoneal papillary serous carcinoma, peritoneal adenocarcinoma of Müllerian type, serous surface papillary carcinoma, normal sized ovary carcinoma syndrome, peritoneal mesothelioma, and primary peritoneal carcinoma. This illustrates the confusion about definition, histogenesis and clinicopathologic features of this entity. In 1993, in an attempt to sort out these confounding variables, the Gynecologic Oncology Group (GOG) developed criteria to define EOPPC: - Both ovaries must be either physiologically normal in size or enlarged by a benign process. - The involvement in extraovarian sites must be greater than the involvement on the surface of either ovary. - Microscopically, the ovarian component must be one of the following: non existent; confined to ovarian surface epithelium with no evidence of cortical invasion; involving ovarian surface epithelium and underlying cortical stroma but with tumour size less than 5x5mm within ovarian substance with or without surface disease. The histological and cytological characteristics of the tumour must be predominantly of the serous type that is similar or identical to ovarian serous adenocarcinoma of any grade [8, 55].